Lakefront Biotherapeutics (LKFT) vs Prestige Consumer Healthcare (PBH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Lakefront Biotherapeutics (LKFT) has outperformed Prestige Consumer Healthcare (PBH) over the past year, gaining 8.6% versus a loss of 16.5%. Over five years, PBH leads with a -12.0% price change compared with -31.8% for LKFT. Prestige Consumer Healthcare is the larger company by market cap ($2.35 billion vs $2.18 billion), about 1.1 times the size.
On valuation, Lakefront Biotherapeutics trades at a lower trailing P/E (2.4x vs 15.3x for Prestige Consumer Healthcare).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LKFT | PBH |
|---|---|---|
| Share price | $33.31 | $49.63 |
| Market cap | $2.18B | $2.35B |
| 1-day change | -0.24% | +0.06% |
| YTD return | +1.87% | -19.55% |
| 1-year return | +8.64% | -16.48% |
| 5-year return | -31.80% | -12.02% |
| P/E ratio (TTM) | 2.39 | 15.32 |
| Forward P/E | — | 9.76 |
| EPS (TTM) | $13.94 | $3.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.09B |
| Revenue growth (YoY) | — | -4.31% |
| Net income (latest FY) | — | $190.30M |
| Gross margin | — | 54.71% |
| Operating margin | — | 28.42% |
| Net margin | — | 17.48% |
| 52-week high | $36.24 | $71.07 |
| 52-week low | $25.68 | $41.77 |
| Distance from 52-week high | -8.08% | -30.17% |
| Analyst consensus | hold | buy |
| Avg. price target upside | -7.39% | +33.39% |
| Average volume | 280.49K | 583.25K |
| Shares outstanding | 65.48M | 47.40M |
| Employees | 196 | 890 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LKFT has outperformed PBH by 25.1 percentage points over the past year.
- Prestige Consumer Healthcare trades at a higher earnings multiple (15.3x vs 2.4x trailing P/E).
About Lakefront Biotherapeutics
LKFT stock →Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma.
Health Care · Biotechnology: Pharmaceutical Preparations · 196 employees
About Prestige Consumer Healthcare
PBH stock →Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Health Care · Biotechnology: Pharmaceutical Preparations · 890 employees
LKFT vs PBH FAQ
Which is bigger, Lakefront Biotherapeutics or Prestige Consumer Healthcare?
Prestige Consumer Healthcare (PBH) is larger, with a market capitalization of $2.35B compared with $2.18B for Lakefront Biotherapeutics (LKFT).
Which stock has performed better over the past year, LKFT or PBH?
LKFT returned +8.64% over the past 12 months, compared with -16.48% for PBH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, LKFT or PBH?
LKFT has the lower trailing P/E at 2.4, versus 15.3 for PBH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Lakefront Biotherapeutics and Prestige Consumer Healthcare in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.